Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model

Abstract Cryptococcus neoformans is considered a critical fungal pathogen by the World Health Organization and developing a vaccine for cryptococcosis is a top priority. Here, we employed mRNAs encoding an antigen(s) packaged in lipid nanoparticles (LNPs) to develop vaccines for cryptococcosis. Rema...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeqi Li, Suresh Ambati, Richard B. Meagher, Xiaorong Lin
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01079-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863265359298560
author Yeqi Li
Suresh Ambati
Richard B. Meagher
Xiaorong Lin
author_facet Yeqi Li
Suresh Ambati
Richard B. Meagher
Xiaorong Lin
author_sort Yeqi Li
collection DOAJ
description Abstract Cryptococcus neoformans is considered a critical fungal pathogen by the World Health Organization and developing a vaccine for cryptococcosis is a top priority. Here, we employed mRNAs encoding an antigen(s) packaged in lipid nanoparticles (LNPs) to develop vaccines for cryptococcosis. Remarkably, when coupled with capsule adjuvant, vaccination with CDA1-LNPs protected the vast majority of mice from the otherwise lethal cryptococcosis. These results support the promise of mRNA-LNP vaccines against fungal diseases.
format Article
id doaj-art-46b721344144445498a7895ada06b798
institution Kabale University
issn 2059-0105
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj-art-46b721344144445498a7895ada06b7982025-02-09T12:11:06ZengNature Portfolionpj Vaccines2059-01052025-02-011011710.1038/s41541-025-01079-zDeveloping mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine modelYeqi Li0Suresh Ambati1Richard B. Meagher2Xiaorong Lin3Department of Microbiology, University of GeorgiaDepartment of Genetics, University of GeorgiaDepartment of Genetics, University of GeorgiaDepartment of Microbiology, University of GeorgiaAbstract Cryptococcus neoformans is considered a critical fungal pathogen by the World Health Organization and developing a vaccine for cryptococcosis is a top priority. Here, we employed mRNAs encoding an antigen(s) packaged in lipid nanoparticles (LNPs) to develop vaccines for cryptococcosis. Remarkably, when coupled with capsule adjuvant, vaccination with CDA1-LNPs protected the vast majority of mice from the otherwise lethal cryptococcosis. These results support the promise of mRNA-LNP vaccines against fungal diseases.https://doi.org/10.1038/s41541-025-01079-z
spellingShingle Yeqi Li
Suresh Ambati
Richard B. Meagher
Xiaorong Lin
Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
npj Vaccines
title Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
title_full Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
title_fullStr Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
title_full_unstemmed Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
title_short Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
title_sort developing mrna lipid nanoparticle vaccine effective for cryptococcosis in a murine model
url https://doi.org/10.1038/s41541-025-01079-z
work_keys_str_mv AT yeqili developingmrnalipidnanoparticlevaccineeffectiveforcryptococcosisinamurinemodel
AT sureshambati developingmrnalipidnanoparticlevaccineeffectiveforcryptococcosisinamurinemodel
AT richardbmeagher developingmrnalipidnanoparticlevaccineeffectiveforcryptococcosisinamurinemodel
AT xiaoronglin developingmrnalipidnanoparticlevaccineeffectiveforcryptococcosisinamurinemodel